Anaesthesia for renal transplant surgery: An update

European Journal of Anaesthesiology

Volumn 29, Issue 12, 2012, Pages 552-558

  Schmid, Sebastian ^a   Jungwirth, Bettina ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anaesthesia; Kidney; Postoperative care; Transplantation

Indexed keywords

ATRACURIUM BESILATE; CARBON DIOXIDE; CISATRACURIUM; DESFLURANE; DOBUTAMINE; DOPAMINE; ENFLURANE; ERYTHROPOIETIN; ETOMIDATE; FENTANYL DERIVATIVE; FUROSEMIDE; HYPERTENSIVE FACTOR; INHALATION ANESTHETIC AGENT; ISOFLURANE; MANNITOL; MORPHINE; NORADRENALIN; PANCURONIUM; PROPOFOL; RINGER LACTATE SOLUTION; ROCURONIUM; SEVOFLURANE; SODIUM CHLORIDE; SUGAMMADEX; SUXAMETHONIUM; THIOPENTAL;

ANESTHESIA; BLOOD OXYGEN TENSION; BLOOD PRESSURE MONITOR; BLOOD TRANSFUSION; CARBON DIOXIDE ABSORBENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COLLOID; COMORBIDITY; CORONARY ARTERY DISEASE; CRYSTALLOID; DIABETES MELLITUS; DIALYSIS; ELECTROCARDIOGRAM; FLUID THERAPY; GRAFT FAILURE; HEART INFARCTION; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHROTOXICITY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; SURGICAL RISK;

ADULT; AGED; ANESTHESIA; ANESTHETICS; BLOOD TRANSFUSION; COLLOIDS; EUROPE; HEMODYNAMICS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK; TIME FACTORS;

EID: 84872259622     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32835925fc     Document Type: Review

References (91)

1. Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 1955; 67:167-173.
2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730.
3. Gill J, Bunnapradist S, Danovitch GM, et al. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 2008; 52:541-552.
4. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and waitlisted transplant candidates. J Am Soc Nephrol 2001; 12:589-597.
5. Saxena R, Yu X, Giraldo M, et al. Renal transplantation in the elderly. Int Urol Nephrol 2009; 41:195-210.
6. Chavalitdhamrong D, Gill J, Takemoto S, et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation 2008; 85:1573-1579.
7. Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58:859-866.
8. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients: a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8:50-57.
9. Bronzatto EJ, da Silva Quadros KR, Santos RL, et al. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function - a single center analysis. Transplant Proc 2009; 41: 849-851.
10. De Gasperi A, Narcisi S, Mazza E, et al. Perioperative fluid management in kidney transplantation: is volume overload still mandatory for graft function? Transplant Proc 2006; 38:807-809.
11. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006; 17:900-907.
12. de Lusignan S, Chan T, Stevens P, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22:234-241.
13. McClellan WM, Chertow GM. Beyond Framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol 2005; 16:1539-1541.
14. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) - developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:418-499.
15. Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant 1998; 13 (Suppl 6):66-73.
16. Fliser D, Franek E, Joest M, et al. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997; 51:1196-1204.
17. Ansell D. UK Renal Registry 11th annual report (December 2008). Chapter 1: Summary of findings in the 2008 UK Renal Registry report. Nephron Clin Pract 2009; 111 (Suppl 1):1-2.
18. Gaston RS, Danovitch GM, Adams PL, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003; 3:775-785.
19. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010; 27:92-137.
20. Kikic Z, Lorenz M, Sunder-Plassmann G, et al. Effect of hemodialysis before transplant surgery on renal allograft function: a pair of randomized controlled trials. Transplantation 2009; 88:1377-1385.
21. Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002; 62:1423-1430.
22. Tejchman K, Domanski L, Sienko J, et al. Influence of perioperational acidbase balance disorders on early graft function in kidney transplantation. Transplant Proc 2007; 39:848-851.
23. Parekh J, Niemann CU, Dang K, Hirose R. Intraoperative hyperglycemia augments ischemia reperfusion injury in renal transplantation: a prospective study. J Transplant 2011; (ePub).
24. Annual Report of Eurotransplant 2011; p. 49; http://www.eurotransplant. org/cms/index.php?page=yearlystats.
25. Witczak BJ, Leivestad T, Line PD, et al. Experience from an active preemptive kidney transplantation program: 809 cases revisited. Transplantation 2009; 88:672-677.
26. Cecka JM. The OPTN/UNOS Renal Transplant registry. Clinical Transplants UCLA Tissue Typing Laboratory: Los Angeles, 2005: 1-16.
27. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360:459-469.
28. Genc V, Ozgencil E, Orozakunov E, et al. Pure laparoscopic versus open live donor nephrectomy: evaluation of health survey and graft functions. Transplant Proc 2011; 43:791-794.
29. Ungbhakorn P, Kongchareonsombat W, Leenanupan C, et al. Comparative outcomes of open nephrectomy, hand-assisted laparoscopic nephrectomy, and full laparoscopic nephrectomy for living donors. Transplant Proc 2012; 44:22-25.
30. Mertens zur Borg IR, Di Biase M, Verbrugge S, et al. Comparison of three perioperative fluid regimes for laparoscopic donor nephrectomy: a prospective randomized dose-finding study. Surg Endosc 2008; 22:146-150.
31. Gonsowski CT, Laster MJ, Eger EI, et al. Toxicity of compound A in rats. Effect of a 3-h administration. Anesthesiology 1994; 80:556-565.
32. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIFE), in Sprague- Dawley rats. Anesthesiology 1995; 83:1220-1232.
33. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997; 86:1231-1237.
34. Conzen PF, Kharasch ED, Czerner SF, et al. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97:578-584.
35. Teixeira S, Costa G, Costa F, et al. Sevoflurane versus isoflurane: does it matter in renal transplantation? Transplant Proc 2007; 39:2486- 2488.
36. Litz RJ, Hubler M, Lorenz W, et al. Renal responses to desflurane and isoflurane in patients with renal insufficiency. Anesthesiology 2002; 97:1133-1136.
37. Eichhorn JH, Hedley-Whyte J, Steinman TI, et al. Renal failure following enflurane anesthesia. Anesthesiology 1976; 45:560-564.
38. Conzen PF, Nuscheler M, Melotte A, et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 1995; 81:569-575.
39. Folwaczny C, Hundegger K, Volger C, et al. Measurement of transit disorders in different gastrointestinal segments of patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal-detector test. Z Gastroenterol 1995; 33:517-526.
40. Gaber AO, Oxley D, Karas J, et al. Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis 1991; 9:437-443.
41. Walton JD, Farman JV. Suxamethonium hyperkalaemia in uraemic neuropathy. Anaesthesia 1973; 28:666-668.
42. Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104:158-169.
43. Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2008:CD002788.
44. Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71:222-226.
45. Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104:31-39.
46. Staals LM, Snoeck MM, Driessen JJ, et al. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101:492-497.
47. Fahey MR, Rupp SM, Fisher DM, et al. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 1984; 61:699-702.
48. Jirasiritham S, Tantivitayatan K. A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation. J Med Assoc Thai 2004; 87:73-79.
49. Modesti C, Sacco T, Morelli G, et al. Balanced anestesia versus total intravenous anestesia for kidney transplantation. Minerva Anestesiol 2006; 72:627-635.
50. Parker CJ, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 1988; 61:531-540.
51. Eastwood NB, Boyd AH, Parker CJ, Hunter JM. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 1995; 75:431-435.
52. Head-Rapson AG, Devlin JC, Parker CJ, Hunter JM. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. Br J Anaesth 1995; 75:31-36.
53. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011; 37:901- 910.
54. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005; 33:311-322.
55. Cantarovich F, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebocontrolled, multicenter trial. Am J Kidney Dis 2004; 44:402-409.
56. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12:2592-2596.
57. Tiggeler RG, Berden JH, Hoitsma AJ, Koene RA. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 1985; 201:246-251.
58. van Valenberg PL, Hoitsma AJ, Tiggeler RG, et al. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation 1987; 44:784-788.
59. Weimar W, Geerlings W, Bijnen AB, et al. A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation 1983; 35:99-101.
60. Niemann CU, Eilers H. Abdominal organ transplantation. Minerva Anestesiol 2010; 76:266-275.
61. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178.
62. Ferris RL, Kittur DS, Wilasrusmee C, et al. Early hemodynamic changes after renal transplantation: determinants of low central venous pressure in the recipients and correlation with acute renal dysfunction. Med Sci Monit 2003; 9:CR61-CR66.
63. Othman MM, Ismael AZ, Hammouda GE. The impact of timing of maximal crystalloid hydration on early graft function during kidney transplantation. Anesth Analg 2010; 110:1440-1446.
64. Bacchi G, Buscaroli A, Fusari M, et al. The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience. Transplant Proc 2010; 42:3387-3391.
65. de Wilde RB, Schreuder JJ, van den Berg PC, Jansen Jr. An evaluation of cardiac output by five arterial pulse contour techniques during cardiac surgery. Anaesthesia 2007; 62:760-768.
66. O'Malley CM, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: results of a US survey. Transplant Proc 2002; 34:3142-3145.
67. Khajavi MR, Etezadi F, Moharari RS, et al. Effects of normal saline vs. lactated ringer's during renal transplantation. Ren Fail 2008; 30:535-539.
68. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100:1518-1524.
69. Halperin ML, Kamel KS. Potassium. Lancet 1998; 352:135-140.
70. Hadimioglu N, Saadawy I, Saglam T, et al. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008; 107:264-269.
71. Dawidson I, Peters P, Sagalowsky A, et al. The effect of intraoperative fluid management on the incidence of acute tubular necrosis. Transplant Proc 1987; 19:2056-2057.
72. Dawidson IJ, Sandor ZF, Coorpender L, et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 1992; 53:774-782.
73. Willms CD, Dawidson IJ, Dickerman R, et al. Intraoperative blood volume expansion induces primary function after renal transplantation: a study of 96 paired cadaver kidneys. Transplant Proc 1991; 23:1338-1339.
74. Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2003:CD001319.
75. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study [in French]. Ann Fr Anesth Reanim 1994; 13:301-310.
76. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006; 23:721-738.
77. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25:258-268.
78. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348:1620-1622.
79. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14:1517-1520.
80. Hokema F, Ziganshyna S, Bartels M, et al. Is perioperative low molecular weight hydroxyethyl starch infusion a risk factor for delayed graft function in renal transplant recipients? Nephrol Dial Transplant 2011; 26:3373- 3378.
81. Wu Y, Wu AS, Wang J, et al. Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl) 2010; 123:3079-3083.
82. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125- 139.
83. Carpenter CB. Blood transfusion effects in kidney transplantation. Yale J Biol Med 1990; 63:435-443.
84. Scheeren TW, Martin K, Maruschke M, Hakenberg OW. Prognostic value of intraoperative renal tissue oxygenation measurement on early renal transplant function. Transpl Int 2011; 27:687-696.
85. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a metaanalysis. Crit Care Med 2001; 29:1526-1531.
86. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002; 28:877-883.
87. Ciapetti M, di Valvasone S, di Filippo A, et al. Low-dose dopamine in kidney transplantation. Transplant Proc 2009; 41:4165-4168.
88. Kim JM, Kim SJ, Joh JW, et al. Is it safe to use a kidney from an expanded criteria donor? Transplant Proc 2011; 43:2359-2362.
89. Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med 2008; 36:S179-S186.
90. Schenker P, Ozturk A, Vonend O, et al. Single-dose thymoglobulin induction in living-donor renal transplantation. Ann Transplant 2011; 16:50-58.
91. Klouche K, Amigues L, Massanet P, et al. Outcome of renal transplant recipients admitted to an intensive care unit: a 10-year cohort study. Transplantation 2009; 87:889-895.